98%
921
2 minutes
20
Aim: To explore the correlation between a singular value of additive OGTT scores and adverse maternal and neonatal outcomes. We postulated that a higher additive OGTT score would predict poorer maternal and neonatal outcomes.
Methods: In this retrospective cohort study, data were collected from all women with a documented complete OGTT result and subsequent diagnosis of GDM. The additive OGTT score was calculated by adding each individual hourly glucose measurement. Maternal demographics, pregnancy and labor characteristics, and neonatal outcomes were compared between the lower-sum and higher-sum OGTT groups. A multivariate regression analysis was performed to identify confounders associated with adverse outcomes.
Results: In this study, a total of 1497 patients were assessed. The group with higher-sum OGTT scores was characterized by increased rates of GDMA2 (p = 0.008), higher insulin doses (p = 0.009), and higher rates of composite maternal and neonatal adverse outcomes (p = 0.021 and p = 0.030, respectively) compared to the lower-sum OGTT group.
Conclusion: The additive OGTT score may aid in predicting the need for insulin treatment, labor course, and neonatal outcomes in GDM patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00404-024-07455-9 | DOI Listing |
Cureus
August 2025
Bioresource Engineering, Sejong University, Seoul, KOR.
Background Type 2 diabetes (T2D) is a complex metabolic disorder characterized by impaired glucose regulation and insulin resistance and frequently accompanied by obesity and dyslipidemia. The search for novel therapeutic agents to manage these metabolic parameters remains ongoing. Pepper fruit (cv.
View Article and Find Full Text PDFBiomedicines
July 2025
Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
The most common female endocrinopathy is polycystic ovary syndrome (PCOS), affecting 10-20% of women of reproductive age. It is associated with a wide range of hormonal and biochemical abnormalities and long-term metabolic and cardiovascular risks. It is characterized by infertility due to chronic anovulation, hyperandrogenism, polycystic ovarian morphology, and is often associated with insulin resistance (IR) and obesity.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
August 2025
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Context: Oral glucose tolerance test (OGTT) induces greater acute suppression of bone resorption than isoglycaemic intravenous glucose infusions (IIGI).
Objective: To study the separate and combined effects of the gut-derived hormones glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1) and glucagon-like peptide 2 (GLP-2) on postprandial bone turnover.
Design: A randomized, crossover study with 6 experimental days.
Sci Rep
August 2025
Department of Endocrinology, General Hospital of Northern Theater Command, Shenyang, 110016, China.
Our objective was to investigate the potential of lutein in enhancing the efficacy of metformin in diabetes treatment and the underlying mechanisms involved. Here, the study was conducted with type 2 diabetic mice, which was induced by a high-fat diet with streptozotocin. Twenty-four diabetic model mice were divided into four groups: model control group, metformin group, lutein group, and lutein combined with metformin (Lut_Met) group.
View Article and Find Full Text PDFJ Eat Disord
August 2025
Department of Child and Adolescent Psychiatry, Ufuk University Faculty of Medicine, Ankara, Turkey.
Background: Executive functioning (EF) difficulties may play a significant role in the vicious cycle of overeating and metabolic disturbances. We aimed to investigate the correlates of EF difficulties in terms of food addiction symptoms, eating attitudes, and metabolic syndrome markers among adolescents seeking obesity treatment.
Methods: Thirty-five adolescents seeking obesity treatment were included.